There is a correlation between PLK4 expression in gliomas and tumor grades, subtypes, and new WHO types of gliomas (IDH mutation +1p19q codel, IDH mutation +1p19q non-codel, and IDH wild type) (Supplementary Figures 1A–L). The gene discussed is IDH1; the disease is central nervous system cancer.